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Abstract. 
 
Three overlapping pathways mediate the
transport of cytoplasmic material to the vacuole in
 
Saccharomyces cerevisiae
 
. The cytoplasm to vacuole tar-
geting (Cvt) pathway transports the vacuolar hydrolase,
aminopeptidase I (API), whereas pexophagy mediates
the delivery of excess peroxisomes for degradation. Both
the Cvt and pexophagy pathways are selective processes
 
that speciﬁcally recognize their cargo. In contrast,
 
macroautophagy nonselectively transports bulk cytosol to
the vacuole for recycling. Most of the import machinery
characterized thus far is required for all three modes of
transport. However, unique features of each pathway
dictate the requirement for additional components that
differentiate these pathways from one another, including
at the step of speciﬁc cargo selection.
We have identiﬁed Cvt9 and its 
 
Pichia pastoris
 
 coun-
terpart Gsa9. In 
 
S. cerevisiae
 
, Cvt9 is required for the
selective delivery of precursor API (prAPI) to the
 
vacuole by the Cvt pathway and the targeted degrada-
 
tion of peroxisomes by pexophagy. In 
 
P. pastoris
 
, Gsa9
 
is required for glucose-induced pexophagy. Signiﬁcantly,
neither Cvt9 nor Gsa9 is required for starvation-induced
nonselective transport of bulk cytoplasmic cargo by
 
macroautophagy. The deletion of 
 
CVT9
 
 destabilizes the
 
binding of prAPI to the membrane and analysis of
 
a 
 
cvt9
 
 temperature-sensitive mutant supports a direct
role of Cvt9 in transport vesicle formation. Cvt9 oligo-
 
mers peripherally associate with a novel, perivacuolar
membrane compartment and interact with Apg1, a
Ser/Thr kinase essential for both the Cvt pathway and
 
autophagy. In 
 
P. pastoris
 
 Gsa9 is recruited to concentrated
regions on the vacuole membrane that contact peroxi-
somes in the process of being engulfed by pexophagy.
These biochemical and morphological results demon-
 
strate that Cvt9 and the 
 
P. pastoris
 
 homologue Gsa9 may
function at the step of selective cargo sequestration.
Key words: autophagy • degradation • lysosome •
peroxisome • vacuole
 
Introduction
 
General cell function and homeostasis require the regulated
counterbalancing of protein synthesis and organelle bio-
 
genesis with protein breakdown and the selective degrada-
tion of organelles. The macroautophagy pathway directs the
lysosome-mediated breakdown of bulk cytoplasm, including
proteins, nucleic acids, lipids, and organelles and serves as
the principal cellular degradative process (for review see
Klionsky and Ohsumi, 1999; Kim and Klionsky, 2000). The
general mechanism of autophagy has been conserved from
yeast to mammals. In yeast, starvation conditions mobilize
the autophagic machinery to deliver cytoplasmic constituents
to the vacuole, where substrate digestion and recycling
 
mechanisms ensure cell survival. In mammals, macro-
autophagy  has also been implicated to play a role in cellular
remodeling during development, differentiation, and aging
(Mortimore et al., 1996; Vittorini et al., 1999). In addition,
recent findings that a dysfunctional autophagy pathway
may contribute to the metastasis of certain types of cancers
further underscore the relevance of autophagic degradation
processes in humans (Liang et al., 1999; for review see
Klionsky and Emr, 2000).
 
Biochemical and microscopy studies have outlined the
 
basic steps of macroautophagy in 
 
Saccharomyces cerevisiae
 
(for review see Klionsky and Ohsumi, 1999). Upon induc-
tion, double-membrane vesicles, termed autophagosomes,
capture bulk cytoplasm before being targeted to the vacuole.
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Fusion of the autophagosome with the vacuole membrane
releases a single-membrane vesicle, the autophagic body,
into the vacuolar lumen. Subsequent breakdown of the au-
tophagic body releases its cytoplasmic contents for diges-
tion and recycling.
Insights into the molecular details of macroautophagy
have been greatly facilitated through molecular genetic
studies in 
 
S. cerevisiae 
 
(Tsukada and Ohsumi, 1993;
Thumm et al., 1994; for review see Kim and Klionsky,
2000). The cloning of the genes that complement these
yeast macroautophagy mutants, 
 
apg 
 
and 
 
aut
 
, has subse-
quently led to the identification of mammalian homo-
logues of key macroautophagy components, thus support-
ing the conserved nature of this pathway across eukaryotic
kingdoms. The identified machinery includes a group of
components required for transducing the signal for au-
tophagy induction to downstream effectors. Chief among
these is the phosphatidylinositol 3-kinase homologue, Tor.
Activation of Tor represses autophagy, whereas its inhibi-
tion by nutrient starvation conditions or with the immuno-
suppressant drug rapamycin triggers the pathway (Noda
and Ohsumi, 1998). The activity of Tor also affects the
phosphorylation state of Apg13 and the downstream ki-
nase activity of Apg1 (Kamada et al., 2000). Tor-depen-
dent hyperphosphorylation of Apg13 lessens the affinity
of Apg13 for the Apg1 kinase and results in reduced ki-
nase activity as well as the inhibition of autophagy. Con-
versely, Tor repression leads to decreased phosphoryla-
tion of Apg13, an increase in the interaction between
Apg13 and Apg1, and the induction of autophagy.
The formation and completion of autophagosomes re-
quires the function of a novel Apg protein conjugation sys-
tem which results in the covalent linkage of Apg12 to
Apg5 (Kametaka et al., 1996; Mizushima et al., 1998;
George et al., 2000). The intermediate steps leading to
Apg12–Apg5 conjugation involve Apg7, an E1 ubiquitin
activating enzyme homologue, and Apg10, which func-
tions as a protein conjugating enzyme (Mizushima et al.,
1998; Kim et al., 1999; Shintani et al., 1999; Tanida et al.,
1999). After conjugation of Apg12 to Apg5, the Apg16
protein binds Apg5 noncovalently and dimerizes to link a
pair of conjugates (Mizushima et al., 1999). Mutations in
any one of these components result in the failure of au-
tophagic vesicle formation/completion. Once completed,
autophagosome docking and fusion with the vacuole re-
quires predicted vesicle fusion machinery, including the
homologues of syntaxin (Vam3; Darsow et al., 1997),
SNAP-25 (Vam7; Sato et al., 1998), and a rab-GTPase
(Ypt7; Kim et al., 1999), as well as the class C Vps protein
complex (Rieder and Emr, 1997; Scott et al., 1997; Sato et
al., 2000; Seals et al., 2000). Successful fusion of the au-
tophagosome with the vacuole membrane releases the sin-
gle-membrane autophagic body into the vacuole lumen
(Takeshige et al., 1992; Baba et al., 1994, 1995). Break-
down of these vesicles, which exposes the autophagic
cargo for digestion and recycling, requires the acidification
of the vacuole (Nakamura et al., 1997), as well as the vacu-
olar protease Prb1 (Takeshige et al., 1992) and the puta-
tive lipase Cvt17 (Scott et al., 1997; Teter et al., 2001).
The majority of the components required for starva-
tion-induced macroautophagy are also employed to
transport selective cargo. Under nutrient-rich condi-
 
tions, the cytoplasm to vacuole targeting (Cvt)
 
1
 
 path-
way transports the resident hydrolase aminopeptidase I
(API) to the vacuole (Klionsky et al., 1992). The overlap
in transport machinery between autophagy and the Cvt
pathway reflects the mechanistic similarities between the
two pathways (Harding et al., 1996; Scott et al., 1996).
Precursor API (prAPI) is packaged in double-membrane
vesicles (Cvt vesicles) that are substantially smaller than
autophagosomes and appear to exclude bulk cytoplasm
(Baba et al., 1997; Scott et al., 1997). Completed Cvt ves-
icles fuse with the vacuole and release a single-mem-
brane vesicle (Cvt body) into the vacuolar lumen (Scott
et al., 1997). The breakdown of the Cvt body releases
prAPI into its resident lumenal environment, where it is
proteolytically processed to the mature form (Klionsky
et al., 1992).
In addition to the Cvt pathway, macroautophagy ma-
chinery is essential for the selective delivery of excess per-
oxisomes to the vacuole by the related pexophagy path-
way (for review see Kim et al., 2000). Defects in autophagy
components compromise peroxisome degradation in 
 
S.
cerevisiae
 
 (Hutchins et al., 1999). In the methylotrophic
yeast 
 
Pichia pastoris
 
, vacuole-mediated degradation of
peroxisomes after glucose adaptation utilizes a micropex-
ophagic mechanism in which designated excess peroxi-
somes are directly engulfed by the vacuole (Tuttle and
Dunn, 1995; Sakai et al., 1998). Despite the difference in
the site of sequestration, micropexophagy also clearly re-
quires autophagic machinery as an increasing number of
 
P. pastoris 
 
homologues of autophagy components are be-
ing identified (Yuan et al., 1999).
A key question that remains to be answered is what dif-
ferentiates nonselelective bulk cargo from the specifically
targeted cargo, such as prAPI and peroxisomes? Indis-
criminate packaging of physiologically critical organelles
would result in severe cellular dysfunction. On the other
hand, maintaining excess organelles would be energeti-
cally wasteful, whereas the failure to sequester and de-
grade nonfunctional or malfunctioning organelles could
result in cell death. To provide such specificity, additional
factors are likely required to mediate the sequestration of
particular cargo.
In this study, we have identified Cvt9 in 
 
S. cerevisiae
 
 and
Gsa9 in 
 
P. pastoris
 
, which are structural and functional ho-
mologues. Cvt9 was identified by its requirement for vacu-
ole uptake of prAPI, and Gsa9 by its role in the turnover
of peroxisomal enzymes. Although both Cvt9 and Gsa9
are required for the selective uptake of peroxisomes into
the yeast vacuole for degradation, neither protein is essen-
tial for nonselective macroautophagy induced by nitrogen
starvation. These proteins are associated with a unique
membrane compartment located in a perivacuolar region
of the cell. Our biochemical and morphological results
suggest that Cvt9 and Gsa9 function to selectively seques-
ter cytoplasmic proteins and organelles for degradation
within the vacuole.
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Abbreviations used in this paper:
 
 ALP, alkaline phosphatase;
 
 
 
AOX, al-
cohol oxidase; API, aminopeptidase I; BFP, blue fluorescent protein;
Cvt, cytoplasm to vacuole targeting; GFP, green fluorescent protein; HA,
hemagglutinin; PGK, phosphoglycerate kinase; prAPI, precursor API;
SMD, synthetic minimal medium; td, temperature degron; YNB, yeast
nitrogen base. 
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Materials and Methods
 
Strains
 
The yeast strains used in this study are listed in Table I.
 
Growth Media
 
S. cerevisiae
 
 strains were grown in synthetic minimal medium (SMD: 0.67%
yeast nitrogen base [YNB], 2% glucose, and auxotrophic amino acids and
vitamins as needed). Starvation experiments were carried out in SD-N
(0.17% YNB without ammonium sulfate or amino acids, and 2% glucose).
Peroxisomes were induced by growth in oleic acid medium (YTO: 0.67%
YNB, 0.1% Tween 40, and 0.1% oleic acid). 
 
P. pastoris
 
 strains were grown
in YPD (1% Bacto yeast extract, 2% Bacto peptone, and 2% glucose). Per-
oxisomes were induced by growth in methanol (YNM: 0.67% YNB, 0.4 mg/
liter biotin, and 0.5% vol/vol methanol). Degradation of peroxisomes was
carried out in YND (0.67% YNB, 0.4 mg/liter biotin, and 2% glucose).
 
Antibodies/Antiserum
 
Rabbit antisera against Cvt9 peptides corresponding to amino acids 356–
382 and 534–547 (Multiple Peptide Systems) were generated as described
previously (Klionsky et al., 1992). Antibodies to API, Fox3, and Apg9
have been described (Klionsky et al., 1992; Hutchins et al., 1999; Noda et
al., 2000). Antiserum against phosphoglycerate kinase (PGK) and Pep12
were provided by Dr. Jeremy Thorner (University of California at Berke-
ley, Berkeley, CA; Baum et al., 1978) and Dr. Scott Emr (University of
California at San Diego, La Jolla, CA; Becherer et al., 1996), respectively.
Mouse monoclonal antibodies to Dpm1 and Pho8 were from Molecular
Probes. Antisera and antibodies to the hemagglutinin (HA) and myc
epitopes were from Covance Research Products, Inc.
 
Materials
 
Reagents are identical to those described previously (Kim et al., 1999;
Noda et al., 2000). The copper-inducible promoter-based vectors, pCu416,
 
pCu414, and pCu426, were gifts from Dr. Dennis J. Thiele (University of
Michigan, Ann Arbor, MI; Labbé and Thiele, 1999). The pREMI vector
was a gift from Dr. Benjamin S. Glick (University of Chicago, Chicago,
IL). The pGFP(416)SK and pGFP(426)SK vectors for expressing green
fluorescent protein (GFP) fusions were a gift from Dr. Tom Vida (Univer-
sity of Texas Health Sciences Center, Houston, TX). The temperature de-
gron (td) plasmid was a gift from Dr. Jürgen Dohmen (University of Co-
logne, Cologne, Germany; Dohmen et al., 1994).
 
Cloning CVT9
 
The 
 
cvt9
 
 strain AHY96 (Harding et al., 1996) was transformed with a
YCp50-based yeast genomic library (Rose et al., 1987). The transformed
colonies were subjected to a nitrogen starvation screen as described previ-
ously (Kim et al., 1999). After 30 d, 1 colony out of the first 100 survivors
examined contained mature API. The complementing plasmid was recov-
ered and sequenced using pBR322 oligonucleotides. Partial sequences
were entered into the 
 
Saccharomyces
 
 genome database (SGD; http://
genome-www.stanford.edu/Saccharomyces/) and a 20.9-kb region on
chromosome XVI was identified. A 4,812-bp fragment that comple-
mented the prAPI maturation defect was introduced into pRS414 and
pRS424 by using the endogenous SpeI-BamHI restrictions sites, resulting
in the pCVT9(414) and pCVT9(424) clones. These clones contain the
3,537-bp 
 
CVT9
 
 ORF (YPR049C) plus 585 bp of the 5
 
9
 
 and 690 bp of the 3
 
9
 
noncoding sequences. Alternatively, the 
 
CVT9
 
 gene was amplified from
genomic DNA by PCR and cloned into the vector pBluescript to generate
pBS(CVT9). A 4.8-kb SpeI-BamHI fragment containing the 
 
CVT9
 
 gene
from pBS(CVT9) was cloned into pRS313 to generate p313(CVT9).
 
Isolation of gsa9 Mutants and Cloning GSA9
 
P. pastoris gsa
 
 mutants were isolated after the restriction enzyme–medi-
ated integration of a 2.0-kb pREMI plasmid which contained the Col E1
origin of replication and the Zeocin resistance gene under the control of
the 
 
TEF1
 
 promoter from 
 
S. cerevisiae
 
 and the EM7 promoter of 
 
Esche-
richia coli
 
. Details of the mutagenesis procedure will be described else-
where. Three different 
 
gsa
 
 mutants had a disruption of the 
 
GSA9
 
 gene.
 
Table I. Strains Used in This Study
 
Name Genotype Reference
 
S. cerevisiae
 
 strains
KA311A
 
MAT
 
a
 
 his3 leu2 trp1 ura3
 
Irie et al., 1993
YYK36 KA311A 
 
apg1
 
D
 
::LEU2
 
This study
YYK107 KA311A 
 
cvt9
 
D
 
::URA3
 
This study
SEY6210
 
MAT
 
a
 
 ura3-52 leu2-3,112 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9 mel GAL
 
Robinson et al., 1988
VDY101 SEY6210 
 
apg7
 
D
 
::LEU2
 
  Kim et al., 1999
JKY007 SEY6210 
 
apg9
 
D
 
::HIS3
 
Noda et al., 2000
THY119 SEY6210 
 
cvt3-1
 
Harding et al., 1995
AHY001 SEY6210 
 
cvt9
 
D
 
::HIS3
 
This study
AHY96 SEY6210 
 
cvt9-1
 
Harding et al., 1996
JGYtd9 SEY6210 
 
cvt9
 
D
 
::CVT9
 
-DHFR-Ub-HA This study
AHY1468 SEY6210 
 
cvt10-1
 
Harding et al., 1996
TVY1 SEY6210 
 
pep4
 
D
 
::LEU2
 
Gerhardt et al., 1998
WSY99 SEY6210 
 
ypt7
 
D
 
::HIS3
 
Wurmser and Emr, 1998
TN121
 
MATa leu2-3,112 trp1 ura3-52 pho8
 
D
 
::pho8
 
D
 
60 pho13
 
D
 
::URA3
 
Noda et al., 1995
AHY021 TN121 
 
cvt9
 
D
 
::LEU2
 
This study
TN125
 
MAT
 
a
 
 ade2 his3 leu2 lys2 trp1 ura3 pho8::pho8
 
D
 
60
 
Noda and Ohsumi, 1998
YYK126 TN125
 
 apg1
 
D
 
::LEU2
 
Kamada et al., 2000
YYK127 TN125
 
 cvt9
 
D
 
::LEU2
 
This study
 
P. pastoris
 
 strains
GS115
 
his4
 
Cregg et al., 1985
WDY7
 
his4 gsa7 
 
Yuan et al., 1999
R8 GS115 
 
gsa9-2
 
::Zeocin This study
WDY26 GS115
 
 his4
 
::pWD11 (P
 
GAP
 
 HA-GSA9, HIS4) This study
DMM1 GS115::pDM1 (P
 
AOX1
 
GFP-SKL, Zeocin) This study
ANB23 DMM1 
 
his4
 
::pPS64 (P
 
GAP
 
 GFP-HA-GSA9, HIS4) This study
SMD1163
 
his4 pep4 prb1
 
Tuttle and Dunn, 1995
PPF1
 
his4 arg4
 
Yuan et al., 1997
WDK09
 
PPF1 gsa9
 
D
 
::ARG4
 
This study
ANB12 WDK09 
 
his4
 
::pPS64 (P
 
GAP
 
GFP-HA-GSA9, HIS4) This study 
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gsa9-1
 
 cells had the pREMI vector inserted between Q1068 and Y1069,
 
gsa9-2
 
 between M83 and S84, and 
 
gsa9-3
 
 between R1291 and A1292. Us-
ing the different genomic DNA fragments from the three different allelic
mutants, we were able to completely assemble the 
 
GSA9
 
 gene as well as
700 bp of the 5
 
9
 
 and 600 bp of the 3
 
9
 
 noncoding regions. The genomic se-
quence of 
 
GSA9
 
 reported in this paper has been deposited in the National
Center for Biotechnology Information (EMBL/GenBank/DDBJ acces-
sion number AF309870).
 
Disruption of CVT9 and GSA9
 
The chromosomal 
 
CVT9 
 
locus was deleted by a PCR-based, one-step pro-
cedure (Noda et al., 2000). The auxotrophic 
 
HIS3 
 
gene was amplified
from the pRS313 vector using oligonucleotides that contained vector se-
quences outside of the 
 
HIS3
 
 marker flanked by 
 
CVT9 
 
sequences that en-
code regions at the beginning and end of the 
 
CVT9
 
 ORF. The PCR
product was used to transform yeast strain SEY6210 and the His
 
1
 
 trans-
formants were screened for prAPI accumulation to identify 
 
CVT9
 
 knock-
outs. The 
 
cvt9
 
D
 
 strain was confirmed by tetrad analysis as described previ-
ously (Kim et al., 1999). Alternatively, a 1.1-kb BglII-EcoRV fragment
from within the 
 
CVT9
 
 gene in the plasmid pUC19 was replaced with the
 
LEU2
 
 gene. This plasmid was digested with HindIII and transformed into
the TN125 yeast strain to make strain YYK127. Transformants were se-
lected on the appropriate auxotrophic plates and screened by immunoblot
using antiserum to API.
To disrupt 
 
GSA9
 
, the 
 
S. cerevisiae ARG4 gene with its promoter was
amplified by PCR using primers that contained 52 bp of 59 and 39 regions
of GSA9 and 27 bp of the ARG4 gene. The PCR product was directly used
to transform PPF1 cells. The resulting Arg1 clones were replica-plated to
YNM plates and their inability to degrade alcohol oxidase (AOX) during
glucose adaptation was determined by direct colony assay as described be-
low. The site of ARG4 insertion within WDK09 resulting in the deletion
of .90% of the GSA9 gene was verified by PCR.
Plasmid Constructions
Generation of Epitope-tagged Cvt9. To epitope-tag Cvt9, the BamHI site in
p313(CVT9) was destroyed. A new BamHI site was created after the CVT9
start codon by PCR to make p313[BHI-CVT9]. A DNA fragment encoding
a 33HA or 33myc epitope with BamHI sites on both sides was then ligated
into the newly created BamHI site to generate the p313[33HA-CVT9] or
p313[33myc-CVT9] plasmid. Both plasmids complemented the prAPI ac-
cumulation phenotype of the cvt9D strain (data not shown).
The CVT9td Construct. The method of Dohmen et al. (1994) was used
to construct a temperature-sensitive cvt9 mutant. A 751-bp segment of
CVT9 was amplified by PCR using a primer that included a portion of the
59 untranslated region and incorporated a HindIII site, and a 39 primer
that incorporated an EcoRI site. The PCR product was digested with HindIII
and EcoRI. Plasmid pPW66R was digested with NotI and HindIII and the
1.4-kb fragment containing Ub-DHFRts-HA under the CUP1 promoter
was isolated. The HindIII-EcoRI fragment of CVT9 and the NotI-HindIII
fragment from pPW66R were cloned into the pRS306 vector that had
been digested with NotI and EcoRI. The resulting plasmid, pCVT9td, was
digested with BglII and transformed into yeast. Ura1 transformants were
screened by growing cells in the presence of copper and carrying out im-
munoprecipitations with antiserum to Cvt9. Strain JGYtd9 showed a cop-
per-dependent increase in Cvt9 protein levels and was used for subse-
quent analyses.
Constructs of CVT9 and GFPCVT9 under CUP1 Promoter Control. The
CVT9 ORF was PCR-amplified from pCVT9(414) using oligonucleotides
that incorporated an in-frame XmaI site directly upstream of the start
codon on the 59 primer and a SalI site after the stop codon on the
39 primer. The PCR product was digested with XmaI-SalI and sub-
cloned into pCu416, resulting in pCuCVT9(416). The same restriction-
digested PCR product was subcloned into pCuGFP(416), resulting in
pCuGFPCVT9(416), which contains the CUP1-controlled GFP fused to
the 59 of the CVT9 ORF.
Gsa9 was tagged with the HA epitope at the NH2 terminus by PCR am-
plification from genomic DNA. HA-GSA9 was inserted into the KpnI and
XhoI sites of pIB2 (Sears et al., 1998). This plasmid, pWD11, was linear-
ized by cutting within the HIS4 gene and used to transform GS115 cells.
HA-GSA9 was also inserted into the KpnI and XhoI sites behind the GFP
gene, which had been inserted into the EcoRI site of pIB2. The resulting
plasmid pPS64 containing GFP/HA-GSA9 behind the constitutive and
glucose-inducible GAPDH promoter was linearized by cutting within the
HIS4 gene and used to transform WDK09 and DMM1 cells.
Two-Hybrid Analysis
A two-hybrid screen was carried out using a truncated form of the APG1
ORF lacking the NH2-terminal eight amino acids as the bait plasmid as
described (Kamada et al., 2000).
Nitrogen Survival Assay
Nitrogen starvation analysis was done as described previously (Scott et
al., 1996).
Alkaline Phosphatase Enzyme Assay
Induction of autophagy was estimated as activity of mutated alkaline
phosphatase (ALP; Pho8D60p) with a-napthyl phosphate (Sigma-
Aldrich) as substrate as described (Noda and Ohsumi, 1998).
Measurements of Protein and Peroxisome Degradation
The degradation of peroxisomes in S. cerevisiae was determined by the
loss of thiolase (Fox3) as described previously (Hutchins et al., 1999). The
degradation of peroxisomes in P. pastoris was evaluated by measuring
the loss of AOX during glucose adaptation. Samples were assayed for
AOX activity as described previously (Yuan et al., 1999) at 0 and 6 h after
shifting to glucose. The degradation of cellular proteins during nitrogen
starvation was performed as described previously (Yuan et al., 1999).
Cell Labeling, Immunoprecipitations, and 
Immunoblot Analysis
Radioisotopic labeling of cells, immunoprecipitations, and immunoblot-
ting were performed as described previously (Noda et al., 2000).
Protease Protection and Membrane Flotation Assays
Protease sensitivity of prAPI in the cvt9td and ypt7D strains and mem-
brane flotation experiments were performed as described previously
(Noda et al., 2000).
Subcellular Fractionations
For subcellular fractionation experiments, cvt9D cells transformed with
the pCuCVT9(416) plasmid were induced with 50 mM CuSO4 for 1 h at
midlog stage and then spheroplasted as described previously (Kim et al.,
1999). Spheroplasts were subjected to differential lysis in PS200 lysis
buffer A (20 mM PIPES, pH 6.8, 200 mM sorbitol, 5 mM MgCl2) contain-
ing the Complete™ EDTA-free protease inhibitor cocktail (Roche
Molecular Biochemicals) and 1 mM PMSF. After a preclearing step at
100 g, 48C, 5 min, the lysate was subjected to low-speed centrifugation at
16,000 g (13,000 rpm) in an Eppendorf 5415D microcentrifuge for 5 min
at 48C. The low-speed supernatant fraction (S13) was further resolved into
high-speed supernatant and pellet fractions (S100 and P100, respectively)
by centrifugation at 100,000 g for 20 min at 48C in a centrifuge (TL100) us-
ing a TLA100.4 rotor (both from Beckman Coulter).
For the biochemical characterization of Cvt9 membrane association,
the total lysate was mixed with an equal volume of 1% Triton X-100 (in
PS200), 6 M urea (in PS200), 0.1 M Na2CO3, pH 10.5 (in 200 mM sorbitol),
or a 1.0 M salt wash (0.67 M KOAc, 0.3 M KCl). After a 5-min incubation
at 258C, the treated lysates were separated into high speed supernatant
and pellet fractions by centrifugation at 100,000 g for 20 min at 48C.
To assess prAPI binding, cvt9D spheroplasts were lysed in PS200 con-
taining 0, 1, 2, or 5 mM MgCl2 and separated into low-speed supernatant
and pellet fractions by centrifugation at 2,300 g (5,000 rpm) in an Eppen-
dorf 5415D microcentrifuge for 5 min at 258C. All fractionated samples
were subjected to immunoblot analysis.
Optiprep Gradient Analysis
For analysis of Cvt9 by Optiprep gradients, cvt9D cells transformed with
pCuCVT9(416) were incubated with 50 mM CuSO4 for 1 h to induce Cvt9
expression. At midlog stage the cells were spheroplasted and lysed in gra-
dient buffer (PS200 containing 1 mM MgCl2, 1 mM DTT, 1 mM EDTA,
and Complete™ EDTA-free protease inhibitor cocktail). After a pre-
clearing step at 100 g at 48C for 5 min in an Eppendorf 5415D microcentri-
fuge, the lysate was separated into high-speed supernatant and pellet frac-
tions by direct centrifugation at 100,000 g for 20 min at 48C using aKim et al. Cvt9/Gsa9 Functions in the Cvt and Pexophagy Pathways 385
TLA100.4 rotor. The total membrane fraction was resuspended in gradi-
ent buffer and loaded to the top of a 10 ml Optiprep linear gradient
(0–66%) and centrifuged in an SW41 rotor at 100,000 g for 16 h at 48C. 14
fractions were collected and analyzed by immunoblotting.
Microscopy
Confocal Microscopy. The cvt9D cells transformed with pCuGFPCVT9(416)
were induced with 10 mM CuSO4 for 2 h, followed by labeling of vacuoles
with FM 4-64 and viewing the cells using a confocal microscope (IRM; Leica)
as described previously (Kim et al., 1999).
Fluorescence Microscopy. Cells expressing GFP/HA-Gsa9 were grown
in glucose or methanol for 2–24 h. FM 4-64 (20 mg/ml) was added and the
cells were incubated for an additional 16 h. Cells grown on methanol were
transferred to glucose medium for 1–3 h. The cells were then washed and
examined immediately using an Axiophot fluorescence microscope
(ZEISS). Image capture was done using a SPOT digital camera (Diagnos-
tic Instruments, Inc.) with Adobe Photoshop® software.
Electron Microscopy. Cells were grown for 40 h in medium supple-
mented with 0.5% methanol and then transferred to medium containing
2% glucose for 2 h. The cells were washed with distilled water and fixed in
1.5% KMnO4. The cells were then dehydrated, embedded in Epon 812,
and sectioned for viewing on a JEOL 100CX transmission electron micro-
scope (Yuan et al., 1999).
Coimmunoprecipitation of Cvt9 and Apg1
Cells expressing the NH2-terminally myc-tagged Cvt9 and HA-tagged
Apg1 were grown to midlog phase in YPD and spheroplasted as described
previously (Kamada et al., 2000). The spheroplasts were lysed with ice-
chilled Tween lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 0.4 mM Na3VO4, 50 mM KF, 20 mg/ml leupeptin, 20
mg/ml benzamidine, 10 mg/ml pepstatin A, 40 mg/ml aprotinin, 1 mM
PMSF, and 0.5% Tween-20). The lysate was centrifuged at 4,000 g for 5
min and precleared with 20 ml of protein G–Sepharose (50% suspension)
for 30 min at 48C. The cell lysate (500 ml) was incubated with or without 3
ml of anti-Apg1 antiserum for 2.5 h at 48C. Immunocomplexes were col-
lected on protein G–Sepharose beads and washed three times with Tween
lysis buffer. The resultant immunocomplexes were subjected to 7.5%
SDS-PAGE and analyzed further by immunoblotting with anti-myc ascite
(9E10) to detect myc-tagged Cvt9 or with anti-HA ascite (16B12) to de-
tect HA-tagged Apg1. Coimmunoprecipitation of 33HA-Cvt9 and
33myc-Cvt9 was performed in essentially the same manner.
Results
The apg and cvt mutants share a significant genetic over-
lap, indicating a mechanistic convergence between autoph-
agy and the Cvt pathway (for review see Kim and Klion-
sky, 2000). Therefore, the strong sensitivity to nitrogen
starvation displayed by most autophagy mutants has been
used as a phenotypic screen to isolate the complementing
plasmids for the majority of the cvt and apg mutants cloned
thus far. Although cvt9 exhibited only marginal sensitivity
to nitrogen starvation, we nevertheless used the starvation
screen in an attempt to enrich for cvt9 cells containing the
CVT9-complementing plasmid. The cvt9 mutant was trans-
formed with a yeast genomic library and subjected to nitro-
gen starvation. After 30 d of this regime, 1 out of the first
100 surviving colonies screened exhibited a reversal of the
prAPI accumulation phenotype. The plasmid was isolated
and the complementing ORF was determined to be
YPR049C, which was named CVT9. Further genetic analy-
sis confirmed that CVT9 mapped to the same locus as the
original cvt9 mutation (see Materials and Methods).
Cvt9 Is Required for Cvt Transport but Not Autophagy
The CVT9 single-copy plasmid rescued the prAPI process-
ing defect in the cvt9 mutant strain (Fig. 1 A), although
overexpression of Cvt9 using a multicopy CVT9 plasmid
resulted in a moderate accumulation of prAPI. Although
the CVT9 clone was isolated using the nitrogen starvation
strategy, the viability of the cvt9-null strain remained rela-
tively robust in starvation conditions when compared with
a typical mutant in the autophagy pathway (e.g., cvt10/
apg1; Scott et al., 1996; Fig. 1 B). Viability under starva-
tion conditions reflects a capacity for autophagy, indicat-
ing an ability to recycle cytosolic material after delivery to
the vacuole. Therefore, we next determined if the resis-
tance to nitrogen starvation exhibited by the cvt9D strain
reflects its ability to carry out autophagy.
The proteolytic processing of prAPI to its mature form
in the vacuole provides a useful marker to assess the
proper function of the Cvt pathway in nutrient-rich con-
ditions and the autophagy pathway under starvation con-
ditions (Scott et al., 1996). In mutants that exhibit both
Cvt and autophagy defects (e.g., apg7D; Kim et al., 1999;
Fig. 1 C), prAPI accumulation persists in nutrient-rich as
well as starvation conditions. However, if a mutant dis-
plays a defect only in Cvt transport (e.g., cvt3; Harding et
al., 1995; Scott et al., 1996; Fig. 1 C), then the accumu-
lated prAPI phenotype can be rescued by diverting
prAPI transport from a defective Cvt pathway to a func-
tional autophagy pathway after shifting cells to starvation
conditions. In cvt9D, the prAPI delivery defect observed
in nutrient-rich conditions could be circumvented by a
shift to nitrogen starvation conditions, suggesting that a
functional autophagy pathway exists to transport prAPI
to the vacuole (Fig. 1 C).
To further demonstrate the competence for autophagic
uptake in cvt9D, we examined the recombinant cytosolic
marker protein Pho8D60. Truncating the NH2-terminal
transmembrane domain in the vacuolar hydrolase (ALP
or Pho8) results in its cytosolic localization (Noda et al.,
1995). This modified protein is delivered to the vacuole
solely by autophagy. Proteolytic cleavage of the Pho8D60
propeptide in the vacuole lumen generates the active
form of the enzyme, which can be detected by an activity
assay (Fig. 1 D) or by immunoblot analysis (data not
shown). Wild-type, apg1D, and cvt9D strains were trans-
formed with an integrating plasmid that replaced the
PHO8 gene with pho8D60. Cells were vegetatively grown
to midlog phase and then shifted to nitrogen starvation
conditions to induce autophagy. After 4 h in SD-N, vacu-
olar ALP activity was measured (Fig. 1 D). The ALP ac-
tivity in the wild-type strain increased significantly in SD-N,
indicating that Pho8D60 delivery and subsequent pro-
cessing to its enzymatically active form occurred in the
vacuole. As expected, the shift to SD-N did not increase
the ALP activity in the autophagy-defective strain apg1D.
However, in cvt9D, incubation in nitrogen starvation con-
ditions caused a strong increase in ALP activity, further
demonstrating that Cvt9 is not essential for autophagic
transport.
The fusion of double membrane Cvt vesicles or au-
tophagosomes with the vacuole releases the single-mem-
brane Cvt or autophagic body into the vacuole lumen,
respectively (Baba et al., 1997). The subsequent break-
down of these Cvt or autophagic bodies is dependent on
resident hydrolases, as treatment with protease inhibitors
such as PMSF will prevent the breakdown of these sin-The Journal of Cell Biology, Volume 153, 2001 386
Figure 1. Cvt9 is essential for the Cvt pathway but not for autophagy. (A) CVT9
complements the prAPI transport defect in the cvt9 mutants. Wild-type (WT;
SEY6210), cvt9 (AHY96), and cvt9D (AHY001) strains transformed with either
the centromeric (CEN) or multicopy (2m) CVT9 plasmid (pCVT9) were grown to
midlog phase in SMD. Protein extracts were prepared and analyzed by immuno-
blots using antiserum to API. The positions of precursor and mature API are indi-
cated. (B) The cvt9D strain is largely resistant to nitrogen starvation conditions.
Wild-type (SEY6210), cvt9D (AHY001), and cvt10/apg1 (AHY1468) cells were
grown to midlog phase in SMD and transferred to SD-N as described in Materials
and Methods. Aliquots were removed at the indicated times and spread onto YPD
plates in triplicate. Numbers of viable colonies were determined after 2–3 d. (C)
The accumulation of prAPI in cvt9D can be partially reversed by nitrogen starva-
tion. The apg7D (VDY101), cvt3 (THY119), and cvt9D (AHY001) strains were
grown to midlog phase and shifted to SD-N. Protein extracts were prepared at the
indicated times and analyzed by immunoblots with antiserum to API. (D) ALP
activity assay for autophagy. Wild-type (TN125), apg1D (YYK126), and cvt9D
(YYK127) cells expressing Pho8D60 were shifted from nutrient-rich medium
(white bars) to SD-N nitrogen-depleted medium (black bars) for 4 h. The level of
autophagy induction was determined by an ALP activity assay as described in
Materials and Methods. The graph is the average of three experiments. The cvt9D
strain is not defective in the vacuolar delivery of the autophagy marker Pho8D60
during starvation conditions.
(E) Cvt9 is not required for
the formation of autophago-
somes. The cvt9D (YYK127)
strain was grown in nutrient-
rich (YPD) and nitrogen
starvation (SD-N) condi-
tions supplemented with the
protease inhibitor PMSF and
examined by electron mi-
croscopy as described in
Materials and Methods. In
YPD, Cvt complexes (indi-
cated by an arrow) could be
detected in the cytoplasm. In
SD-N,  cvt9D cells accumu-
lated autophagic bodies in
the vacuole when treated
with PMSF.Kim et al. Cvt9/Gsa9 Functions in the Cvt and Pexophagy Pathways 387
gle-membrane vesicles inside the vacuole (Takeshige et
al., 1992). To obtain morphological evidence for a func-
tional autophagy pathway in the cvt9D strain, cells were
grown in either nutrient-rich or nitrogen starvation con-
ditions in the presence of PMSF and analyzed by electron
microscopy (Fig. 1 E). In nutrient-rich conditions when
cells were treated with PMSF, Cvt bodies did not accu-
mulate in the vacuole. Instead, Cvt complexes could be
occasionally detected in the cytosol, confirming that the
Cvt pathway is defective in the cvt9-null strain. In con-
trast, PMSF treatment of cvt9D cells in nitrogen starva-
tion medium caused a substantial accumulation of au-
tophagic bodies inside the vacuole. Taken together, these
findings demonstrate that Cvt9 is required for the Cvt
pathway, but does not appear to function in autophagic
transport.
The Stability of prAPI Membrane Binding Is 
Compromised in cvt9D
The delivery of prAPI via the Cvt pathway involves the as-
sembly of prAPI oligomers into a Cvt complex that binds a
pelletable membrane fraction in a salt-dependent manner
(Kim et al., 1997). Subcellular fractionation experiments
indicate that prAPI can be recovered entirely in a low-
speed pellet fraction in an osmotic lysis buffer containing 5
mM MgCl2, whereas omitting MgCl2 from the lysis buffer
results in a completely cytosolic distribution of prAPI
(Oda et al., 1996). Furthermore, in vitro reconstitution ex-
periments in buffer containing 5 mM MgCl2 demonstrate
that membrane-bound prAPI can subsequently be trans-
ported into the vacuole, suggesting that the salt-dependent
membrane binding of prAPI represents a bona fide step in
the transport pathway and not a byproduct of protein ag-
gregation (Scott et al., 1996). We next examined the func-
tion of Cvt9 in the context of the stability of prAPI binding
to the membrane fraction. The cvt9D cells were grown
to midlog phase and converted into spheroplasts. The
spheroplasts were lysed in an osmotic lysis buffer in the
presence of titrating concentrations of MgCl2. The lysates
were then separated into low-speed supernatant and pellet
fractions and analyzed by immunoblots using antiserum to
API as described in Materials and Methods. The apg9D
strain was used as a control in which prAPI displays typi-
cal membrane-binding properties. In the absence of salt,
prAPI association with the pellet fraction is severely per-
turbed (Fig. 2 A), consistent with previous reports (Oda et
al., 1996). In a typical cvt/apg mutant such as apg9D, addi-
tion of increasing concentrations of MgCl2 stabilizes the
binding of prAPI to the membrane fraction; substantial
prAPI binding occurred at 1 mM MgCl2 and nearly com-
plete prAPI association with the pellet fraction was de-
tected in 5 mM MgCl2. In contrast, in the cvt9D strain,
aliquot was removed for the total lysate control (T). The pellet
fraction (P) was resuspended in 15% Ficoll-400 and added to the
bottom of a step gradient of 13 and 2% Ficoll-400. The step gra-
dients were centrifuged at 16,000 g for 10 min. Membrane-con-
taining float (F), nonfloat (NF), and pellet (P2) fractions were
immunoprecipitated with antiserum to API as described in Mate-
rials and Methods.
Figure 2. CVT9 mutations destabilize prAPI membrane binding
and cause a defect in vesicle formation. (A) prAPI membrane
binding is destabilized in the cvt9D mutant. The cvt9D (AHY001)
and apg9D (JKY007) strains were grown to midlog phase and
converted to spheroplasts. The spheroplasts were lysed in os-
motic lysis buffer supplemented with 0, 1, 2, or 5 mM MgCl2. The
total lysate (T) was separated into low speed supernatant (S) and
pellet (P) fractions by centrifugation at 2,300 g for 5 min. The
fractionated samples were subjected to immunoblot analysis us-
ing antiserum to API. (B) The temperature-conditional cvt9td
strain is tightly blocked for prAPI import at nonpermissive tem-
perature. Wild-type (WT; SEY6210) and cvt9td (JGY9td) strains
were incubated at 308C and 378C for 5 min, pulse-labeled for 10
min, and then subjected to nonradioactive chase reactions for the
indicated times. Samples at each time point were immunoprecipi-
tated with antiserum to API as described in Materials and Meth-
ods. (C) prAPI in the cvt9td strain is protease accessible. Sphero-
plasts isolated from cvt9td and ypt7D cells were pulse-labeled for
10 min and chased for 30 min at 378C. The labeled spheroplasts
were then osmotically lysed and separated into low-speed super-
natant (S) and pellet (P) fractions after a 2,300-g centrifugation
step. The pellet fractions were subjected to protease treatment in
the absence or presence of 0.2% Triton X-100 as described in
Materials and Methods. (D) prAPI in the cvt9td strain associates
with a floatable membrane fraction. Spheroplasts of apg9ts and
cvt9td were osmotically lysed and separated into supernatant (S)
and pellet (P) fractions by centrifugation at 2,300 g for 5 min. AnThe Journal of Cell Biology, Volume 153, 2001 388
prAPI remained largely in the supernatant fraction even
at 2 mM MgCl2, with significant prAPI membrane binding
occurring only at 5 mM MgCl2. These results indicate that
although Cvt9 is not essential for prAPI membrane bind-
ing, the deletion of CVT9 destabilizes the interactions be-
tween prAPI oligomers and the membrane structure to
which they bind.
Cvt9 Is Required at the Stage of Cvt
Vesicle Formation/Completion
The permanent loss of function in the cvt9D mutant may
result in indirect, secondary phenotypes on the Cvt path-
way. To determine the direct effects of Cvt9 loss of func-
tion, we generated a temperature-sensitive form of Cvt9
by constructing a chimera of Cvt9 linked to the COOH
terminus of Ub-DHFR, resulting in the Cvt9td fusion pro-
tein (Dohmen et al., 1994). The expression of Cvt9td was
placed under the copper-inducible CUP1 promoter. At
permissive temperature (308C), the strain (JGY9td) ex-
pressing the Cvt9td protein was fully functional for the Cvt
pathway and displayed prAPI maturation kinetics that
were similar to the wild-type strain (Fig. 2 B). A shift to
nonpermissive temperature caused the rapid misfolding
and degradation of Cvt9td by proteasome-mediated pro-
teolysis (data not shown; Dohmen et al., 1994). As a con-
sequence, prAPI import was tightly blocked in the cvt9td
mutant at the nonpermissive temperature, whereas prAPI
maturation kinetics remained unaffected in the wild-type
strain (Fig. 2 B). The immediate defect in prAPI process-
ing caused by the thermal inactivation of Cvt9td suggests
that Cvt9 acts directly in the Cvt pathway.
To determine the step of the pathway in which Cvt9
function is required, we analyzed the state of prAPI in the
cvt9td strain by protease sensitivity and membrane flota-
tion assays. Cvt9td expression was induced at midlog
phase for 1 h with 1 mM CuSO4 before spheroplasting. The
cvt9td spheroplasts were radioactively labeled for 5 min
followed by a nonradioactive chase reaction for 30 min
at nonpermissive temperature. The labeled spheroplasts
were then lysed osmotically and separated into low-speed
supernatant and pellet fractions as described in Materials
and Methods. The prAPI-containing pellet fractions were
treated with exogenous proteinase K in the presence or
absence of detergent and then immunoprecipitated with
API antiserum. The supernatant and pellet fractions were
also immunoprecipitated with antiserum to the cytosolic
marker protein PGK to assess the osmotic spheroplast ly-
sis efficiency. The protease sensitivity assay indicates that
at nonpermissive temperature, prAPI in the cvt9td strain
was accessible to exogenous proteases even in the absence
of detergent treatment (Fig. 2 C). The small amount of
protease-resistant prAPI in the cvt9td strain probably re-
flects incomplete spheroplast lysis based on the appear-
ance of a small amount of PGK in the pellet fraction.
Nevertheless, the protease-protection assay of cvt9td at
nonpermissive temperature suggests that Cvt vesicles had
not yet formed to enclose prAPI in this strain. The ypt7D
mutant was used as the control strain. Ypt7 is a rab gua-
nosine triphosphatase required for Cvt vesicle fusion with
the vacuole, and thus the ypt7D strain accumulates prAPI
in a protease-protected state (Fig. 2 C; Kim et al., 1999).
In the membrane flotation gradient analysis, membrane-
associated proteins in a cell lysate migrate to the top of a
step gradient and are collected as the “float” (F) fraction.
Soluble proteins remain in the nonfloat (NF) fraction and
proteins associated with large protein complexes are re-
covered in the gradient pellet fraction (P2). The radiola-
Figure 3. Characterization of Cvt9. (A) Cvt9 forms a ho-
modimer. The wild-type (KA311A) strain was transformed with
a plasmid encoding myc-tagged Cvt9 with or without a second
plasmid for HA-tagged Cvt9. Cell lysates were prepared as de-
scribed in Materials and Methods and immunoprecipitated (IP)
with antiserum to HA (lanes 1 and 3) or buffer control (lanes 2
and 4). The immunoprecipitates were then immunoblotted with
antiserum or antibodies to HA and myc. The anti-HA–precipi-
tated immunocomplex also contains myc-tagged Cvt9. The cell
lysates were also directly immunoblotted with anti-HA and anti-
myc antibodies to assess the expression of the epitope tagged
Cvt9 fusions (lanes 5 and 6). (B) Cvt9 subcellular fractionation
pattern. The cvt9D (AHY001) strain was transformed with a
CVT9 plasmid behind the CUP1 copper-inducible promoter
(pCuCVT9[416]). Expression was induced with 50 mM CuSO4 for
1 h before spheroplasting. The spheroplasts were osmotically
lysed (see Materials and Methods). After a preclearing centrifu-
gation step at 100 g for 5 min to remove unlysed spheroplasts, the
total lysate (T) was separated into low speed supernatant (S13)
and pellet (P13) fractions. The S13 fraction was further separated
into 100,000 g supernatant (S100) and pellet (P100) fractions.
The fractionated samples were subjected to immunoblot analysis
using antiserum to Cvt9 and the cytosolic marker protein PGK.
(C) Cvt9 is a peripheral membrane protein that is detergent resis-
tant. A total lysate was prepared as in B and resuspended in os-
motic lysis buffer only or containing 1% Triton X-100, 6 M urea,
0.1 M Na2CO3, pH 10.5, or a 1.0 M salt wash (0.67 M KOAc, 0.3 M
KCl). The treated lysates were separated into total membrane
(P) and supernatant (S) fractions by centrifugation at 100,000 g
for 20 min at 48C. The samples were analyzed by immunoblots
with antiserum to Cvt9 and antibodies to the ER integral mem-
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beled prAPI pellet fraction derived from the lysate of the
cvt9td strain at nonpermissive temperature was loaded on
the bottom of a step gradient and subjected to centrifuga-
tion. The majority of prAPI from the cvt9td strain was re-
covered in the float fraction, indicating that prAPI associ-
ates with a floatable membrane source (Fig. 2 D). As a
positive control for the flotation gradient analysis, we ex-
amined the prAPI pellet fraction derived from a tempera-
ture-conditional allele of apg9 ( apg9ts). Consistent with
our recent study on Apg9, prAPI from the apg9ts strain as-
Figure 4. Cvt9 is localized to a perivacuolar compartment. (A)
Localization pattern of GFPCvt9. The cvt9D (AHY001) strain
was transformed with a plasmid encoding a GFPCvt9 fusion pro-
tein behind the CUP1 promoter (pCuGFPCVT9). Expression of
GFPCvt9 was induced with 10 mM CuSO4 for 2 h, followed by la-
beling of the vacuoles with FM 4-64 (see Materials and Methods).
Images were taken with a Leica IRM confocal microscope.
GFPCvt9 mostly localizes to intense perivacuolar, punctate struc-
tures. (B and C) Subcellular localization of Cvt9 by Optiprep
density gradients. The cvt9D strain was transformed with
pCuCVT9(416) and incubated with 50 mM CuSO4 at midlog growth stage to induce Cvt9 expression. The cells were converted to
spheroplasts and lysed in gradient lysis buffer (see Materials and Methods). A total membrane fraction was isolated by centrifugation at
100,000 g for 20 min and loaded to the top of a 10-ml Optiprep linear gradient (0–66%). After centrifugation at 100,000 g for 16 h at 48C,
14 fractions were collected and analyzed by immunoblots with antiserum or antibodies to Cvt9 and (B) Pho8 (vacuole), (C) Dpm1
(ER), Kex2 (trans-Golgi Network), and Pep12 (endosome). The immunoblots and the graphs of the densitometry quantitation are from
the same gradient but presented separately for clarity.The Journal of Cell Biology, Volume 153, 2001 390
sociates with a membrane source and is recovered in the
float fraction (Noda et al., 2000). Taken together, these
findings demonstrate that Cvt9 is directly required for the
completion of Cvt vesicles and appears to stabilize the as-
sociation of prAPI with these forming vesicles.
Cvt9 Is an Oligomeric, Coiled Coil, Peripheral 
Membrane Protein
To further understand Cvt9 function in the Cvt pathway,
we next characterized the biosynthesis of the Cvt9 protein.
Polyclonal antiserum raised against synthetic Cvt9 pep-
tides recognized a 135-kD band by immunoblot analysis,
in agreement with its predicted molecular mass (data not
shown). Detection of Cvt9 increased in cvt9D cells trans-
formed with the CVT9 multicopy plasmid and was absent
in the cvt9D cells, suggesting that the antiserum is specific
for the Cvt9 protein. Analysis of the Cvt9 amino acid se-
quence reveals a significant coiled coil secondary struc-
ture between amino acid residues 542 and 851 (http://
nightingale.lcs.mit.edu/cgi-bin/score). The P. pastoris ho-
mologue, Gsa9, also contains a predicted coiled coil sec-
ondary structure motif between amino acids 811 and 1027.
Because a common feature of proteins containing a coiled
coil domain is the ability to form higher-ordered quater-
nary structures, we investigated the possibility that Cvt9
forms oligomers. Extracts from cells expressing NH2-ter-
minally myc-tagged Cvt9 and HA-tagged Cvt9 were pre-
pared and the immunocomplex containing HA-Cvt9 was
immunoprecipitated under native, nonreducing conditions
with antiserum to the HA epitope. A subsequent anti-myc
epitope immunoblot detected the myc-tagged Cvt9 from
the original immunoprecipitated HA–Cvt9 immunocom-
plex, indicating that myc-Cvt9 associates with HA–Cvt9
(Fig. 3 A). These findings indicate that Cvt9 forms ho-
modimers or potentially larger oligomeric structures.
The subcellular location of Cvt9 was initially examined
by subcellular fractionation and differential centrifugation
procedures. The cvt9D strain was transformed with a plas-
mid containing CVT9 behind the CUP1 copper regulable
promoter (Labbé and Thiele, 1999). Cvt9 expression was
induced at midlog phase with 50 mM CuSO4 for 1 h before
spheroplasting. The prAPI accumulation in the cvt9D
strain was completely reversed at this level of Cvt9 expres-
sion (data not shown). The spheroplasts were lysed osmot-
ically and separated into low-speed supernatant and pellet
fractions (S13 and P13, respectively). The S13 supernatant
fraction was further resolved into high-speed supernatant
and pellet fractions (S100 and P100, respectively). The ma-
jority of Cvt9 fractionated to both the P13 and P100 frac-
tions, whereas only a minor population appeared in the
high-speed supernatant fraction (Fig. 3 B). We next inves-
tigated the nature of the Cvt9 pellet association (Fig. 3 C).
The spheroplasts were lysed osmotically and treated with
lysis buffer, Triton X-100, urea, Na2CO3, or a high salt
wash as described in Materials and Methods. The treated
lysates were then subjected to high-speed centrifugation
and separated into total membrane and supernatant frac-
tions. The buffer-only treatment confirmed that the major-
ity of Cvt9 remained bound to a membrane pellet fraction.
However, treatment with urea, Na2CO3, and the high-salt
wash, conditions that remove peripheral membrane pro-
teins, all stripped a substantial portion of Cvt9 from the
membrane pellet into the supernatant fraction. In addi-
tion, examination of Cvt9 by membrane flotation gradient
analysis indicated that Cvt9 was recovered in the “float”
fraction, suggesting that it associated with a floatable
membrane (data not shown). Therefore, we propose that
Cvt9 is a peripheral membrane protein (Fig. 3 C). In con-
trast, the integral membrane protein Dpm1 remained in
the pellet fraction under all conditions, except when mem-
branes were solubilized with detergent. Interestingly, Cvt9
remained in the pellet fraction after treatment with Triton
X-100, suggesting that Cvt9 multimers may form a larger
detergent-resistant protein complex.
Cvt9 Localizes to a Distinct Perivacuolar Compartment
To investigate the identity of the membrane compartment
with which Cvt9 associates, a GFP fusion to the NH2 ter-
minus of Cvt9 was examined. Under the control of the
CUP1 promoter, GFPCvt9 expression complemented the
prAPI defect in the cvt9D strain, indicating that it was a
functional chimera (data not shown). At midlog stage,
cvt9D cells expressing GFPCvt9 were labeled with FM 4-64
to mark the vacuoles and examined by confocal micros-
copy. GFPCvt9 appeared to be concentrated at prominent
punctate structures directly adjacent to FM 4-64–labeled
vacuoles (Fig. 4 A). A weak, cytosolic distribution of
GFPCvt9 was also detected, consistent with the ratio of
Cvt9 found in the membrane pellet and cytosolic superna-
tant fractions by biochemical fractionation analysis (com-
pare Figs. 3 B and 4 A).
The confocal micrographs of GFPCvt9 suggested resi-
dence in a compartment proximal to the vacuole or di-
rectly on the vacuolar membrane in the form of a concen-
trated patch. To identify the Cvt9 compartment relative to
known membrane marker proteins, we next examined
Cvt9 subcellular localization by linear Optiprep density
gradients (Fig. 4, B and C). Expression of Cvt9 was in-
duced with 50 mM CuSO4 for 1 h before spheroplasting. A
total membrane fraction was prepared from osmotically
lysed spheroplasts and resolved on Optiprep gradients as
described in Materials and Methods. Immunoblot analysis
of the collected gradient fractions indicated a peak for
the Pho8-localized vacuole compartment in fraction 1,
whereas the Cvt9 compartment migrated to a much denser
region, with a peak in fraction 10 (Fig. 4 B). This finding
demonstrates that the perivacuolar Cvt9 compartment is
Figure 5. Cvt9 physically associates with Apg1. The apg1D strain
(YYK36) was transformed with a plasmid encoding myc-tagged
Cvt9 (p[myc-CVT9]) with or without an additional plasmid en-
coding Apg1 (p[APG1]). The cell lysates were prepared as de-
scribed in Materials and Methods and subjected to immunopre-
cipitation with anti-Apg1 antiserum (lanes 1, 3, and 5) or buffer
only (lanes 2, 4, and 6). The immunoprecipitates (IP) were ana-
lyzed by immunoblot with antiserum to myc. The anti-Apg1–pre-
cipitated immunocomplex contains myc-tagged Cvt9 (lane 5).Kim et al. Cvt9/Gsa9 Functions in the Cvt and Pexophagy Pathways 391
distinct from the vacuole. Furthermore, the Cvt9 compart-
ment did not appear to cofractionate with any other resi-
dent organelle marker proteins, including Dpm1 (ER),
Kex2 (late Golgi apparatus), and Pep12 (endosome) (Fig.
4 C). Taken together, the identity of the perivacuolar com-
partment to which Cvt9 localizes appears to be distinct
from known organelles of the endomembrane system.
Cvt9 Physically Interacts with the Apg1 Kinase
Cvt9 is present in a detergent-resistant form, presumably a
protein complex, which localizes to a distinct membrane
compartment (Figs. 3 and 4). We next identified an addi-
tional factor of the Cvt9 protein complex. A two-hybrid
analysis to identify proteins that associate with the autoph-
agy component Apg1 identified Cvt9 as a potential inter-
acting partner (Kamada et al., 2000). The Apg1–Cvt9
interaction was directly supported by a coimmunopre-
cipitation analysis (Fig. 5). The apg1D strain was trans-
formed with the plasmid encoding the myc-tagged Cvt9
fusion protein with or without a second plasmid encod-
ing Apg1. Cell extracts were immunoprecipitated with an-
tiserum to Apg1 under native, nondenaturing conditions
as described in Materials and Methods. The precipitated
immunocomplexes were then subjected to a denaturing
SDS-PAGE/immunoblot procedure with antiserum to the
myc epitope. In cells expressing both myc–Cvt9 and Apg1,
the immunocomplexes precipitated with the Apg1 antise-
rum also isolated the myc-tagged Cvt9 protein, thus con-
firming the two-hybrid data that Apg1 and Cvt9 physically
interact (Fig. 5, lane 5).
Figure 6. Cvt9 and the P.
pastoris homologue Gsa9 are
required for peroxisome
degradation. (A) The S.
cerevisiae cvt9D strain is
defective in pexophagy. Per-
oxisomes from wild-type
(WT; KA311A) and cvt9D
(YYK107) cells were prolif-
erated in oleic acid medium
and then degraded by shift-
ing to SD-N medium at the
indicated times (see Materi-
als and Methods). Pexoph-
agy was monitored by im-
munoblot analysis of the
peroxisomal thiolase en-
zyme, Fox3. Fox3 levels de-
crease in wild-type cells un-
der pexophagy conditions
but remain constant in cvt9D.
(B) The P. pastoris  gsa9
strain is defective in pexoph-
agy. Peroxisomes from wild-
type (GS115), gsa7 (WDY7),
and gsa9 (R8) cells were pro-
liferated in methanol me-
dium and then degraded by
shifting to glucose medium
for 0 and 6 h (see Materials
and Methods). Pexophagy
was measured by an activity
assay for the peroxisomal
AOX enzyme. AOX activity
decreases in wild-type cells in
glucose adaptation condi-
tions, but remains relatively
high in gsa7 and gsa9 cells.
(C) The P. pastoris gsa9D
strain is not defective in au-
tophagy. Wild-type (GS115),
gsa7 (WDY7), and gsa9 (R8)
cells were radiolabeled with 1 mCi/ml [14C]valine for 16 h. The cells were then shifted to nitrogen-depleted chase medium and the pro-
duction of TCA-soluble radioactivity was measured during 2–24 h of chase. Protein turnover rate in gsa9 cells is comparable to wild-
type cells but relatively low in the autophagy-defective gsa7 cells. (D) The P. pastoris gsa9 mutants are defective at a middle to late stage
of micropexophagy. Wild-type strain (GS115) and mutant strains gsa9-2 (R8) and gsa9D (WDK09) were grown to confluency under
methanol conditions to proliferate peroxisomes. The strains were then shifted to a glucose-containing medium for 2 h to induce peroxi-
some degradation before fixation and processing for electron microscopy (see Materials and Methods). Partially degraded peroxisomes
(Px) were found within the vacuole (V) of the parental GS115 cells. This was not observed in the gsa9-2 and gsa9D mutants. Instead,
arm-like extensions of the vacuole(s) were observed to partially surround the peroxisomes. The nuclei (N) are also indicated.The Journal of Cell Biology, Volume 153, 2001 392
Cvt9 and Its P. pastoris Homologue, Gsa9, Are both 
Required for Peroxisome Degradation
We identified GSA9 as an essential component for the glu-
cose-stimulated peroxisome degradation pathway in P. pas-
toris. Sequence analysis revealed GSA9 to be a structural
and functional homologue of CVT9. Both proteins contain
a predicted coiled coil domain. However, although many
proteins encoded by the S. cerevisiae genome share com-
mon residues in the coiled coil domain, only Cvt9 shows ex-
tensive homology with its P. pastoris counterpart over the
entire sequence. More specifically, a BLAST search with
the NH2-terminal and COOH-terminal Gsa9 domains
(amino acids 1–810 and 1028–1316, respectively) flanking
its predicted coiled coil region was performed against all S.
cerevisiae  proteins (http://genome-www2.stanford.edu/
cgi-bin/SGD/nph-blast2sgd). The BLAST results identified
the corresponding NH2-terminal and COOH-terminal do-
mains flanking the coiled coil region of Cvt9 as the only
sequences with statistically significant similarity to Gsa9
(P value, 3.9 3 10219 and 3.9 3 10217, respectively). This se-
quence analysis indicates that Cvt9 is the sole homologue
of Gsa9 in S. cerevisiae and does not represent one member
in a family of related proteins.
To determine if Cvt9 was also required for the specific
degradation of peroxisomes in S. cerevisiae, we examined
the degradation of Fox3, the peroxisomal thiolase enzyme,
following a previously described method for examining
pexophagy in S. cerevisiae (Hutchins et al., 1999). Peroxi-
some proliferation was induced in cvt9D and wild-type
cells by growth in oleic acid medium. Upon shift to SD-N
medium to induce pexophagy, peroxisome degradation
was examined by monitoring cellular Fox3 levels over
the indicated time course (Fig. 6 A). In wild-type cells,
Fox3 levels decreased significantly over the time course,
whereas they remained constant in cvt9D cells. This find-
ing suggests that Cvt9 is required for the specific, vacuolar
delivery of not only prAPI via the Cvt pathway, but also
peroxisomes via the pexophagy pathway in S. cerevisiae.
The P. pastoris gsa9 mutant was further characterized to
better understand the cellular function of Gsa9. Peroxi-
somes and the expression of resident enzymes, such as
AOX, were induced in methanol-containing medium. The
peroxisomes were then degraded upon shift to glucose-
containing medium. After a 6-h incubation in glucose ad-
aptation conditions, AOX activity was measured (Fig. 6
B). Wild-type GS115 cells displayed significant loss of
AOX activity, indicating that excess peroxisomes were de-
graded via pexophagy. As a negative control, gsa7 cells
were analyzed. GSA7 is the P. pastoris homologue of
APG7, an essential component for pexophagy as well as
the Cvt pathway and autophagy (Yuan et al., 1999). Both
gsa7 and gsa9 cells retained substantial AOX activity upon
glucose adaptation, confirming the roles of these proteins
in peroxisome degradation.
As we have noted, Cvt9 does not play an integral role in
starvation-induced autophagy (Fig. 1). If Gsa9 functions in
an analogous manner, then gsa9 mutants should also be
competent for autophagic degradation. Autophagy ac-
counts for the majority of the cellular degradative capacity
during starvation conditions (for review see Kim and
Klionsky, 2000). Thus, the degree of autophagy can be
Figure 7. GFP/HA-Gsa9 localization during glucose adaptation.
ANB23 cells expressing both BFP fused at its COOH terminus
to the serine-lysine-leucine (SKL) peroxisomal targeting signal
(BFP-SKL) and GFP/HA-Gsa9 were grown under methanol
conditions, then adapted to glucose for 4 h. The peroxisomes
were labeled by BFP-SKL (middle). During glucose adaptation,
the GFP/HA-Gsa9 (top) was concentrated to regions of the vac-
uolar membrane that engulf the peroxisomes containing the
BFP-SKL marker (see overlay in bottom panels). A punctate
GFP/HA-Gsa9 pattern was also detected.Kim et al. Cvt9/Gsa9 Functions in the Cvt and Pexophagy Pathways 393
measured in terms of total protein turnover under nitro-
gen starvation conditions. Wild-type, gsa7, and gsa9 cells
were labeled with [14C]valine, followed by a nonradioac-
tive chase reaction in nitrogen starvation medium. The
production of TCA-soluble radioactivity was measured
over the course of 2–24 h. The autophagy-defective gsa7
strain exhibited a low rate of protein turnover, whereas
the relative protein degradation rate in gsa9 cells appeared
similar to the wild-type, suggesting that gsa9 is not defec-
tive in autophagy (Fig. 6 C).
The process of micropexophagy can be categorized into
distinct stages (Sakai et al., 1998). During the early steps of
glucose adaptation, peroxisomes associate with the vacu-
olar membrane. Arm-like extensions of the vacuole ini-
tiate the peroxisome engulfment process. In the middle
stage(s), vacuolar extensions become more pronounced,
ultimately surrounding the peroxisomes. This is followed
by the late stage(s), which involves a homotypic fusion
event to fully enclose the peroxisomes inside the vacuole.
Subsequent breakdown of the peroxisome-containing in-
ner vacuolar vesicle triggers the eventual degradation of
the peroxisomes. To determine the stage at which Gsa9 is
required during micropexophagy, we examined wild-type,
gsa9-2, and gsa9D strains by electron microscopy (Fig. 6
D). In wild-type cells, peroxisomes could be occasionally
detected undergoing degradation in the vacuolar lumen.
However, both gsa9-2 and gsa9D cells exhibited a mi-
cropexophagy defect at a middle/late stage in which vacu-
olar extensions only partially surround the peroxisome but
do not complete the engulfment process.
Gsa9 Is Recruited to the Vacuolar Membrane during 
Peroxisome Uptake
To further characterize the role of Gsa9 in micropexoph-
agy, we examined its localization by fluorescence micros-
copy using a functional GFP/HA-Gsa9 fusion protein.
This construct was able to complement the gsa9D pheno-
type (data not shown). In cells that have not been sub-
jected to glucose adaptation conditions, GFP/HA-Gsa9
appeared localized to one or two structures adjacent to the
vacuole (data not shown). In addition, a weak GFP/HA-
Gsa9 signal was detected coincident with the FM 4-64–
labeled vacuoles. The punctate pattern of GFP/HA-Gsa9
appeared nearly identical to the localization pattern of
GFPCvt9, although we could not detect GFPCvt9 on the
vacuole (Fig. 4 A). When cells expressing GFP/HA-Gsa9
were grown in methanol medium to proliferate peroxi-
somes and then subjected to adaptation in glucose me-
dium, the GFP/HA-Gsa9 signal localized predominantly
to the vacuolar membrane (Fig. 7, top). To compare GFP/
HA-Gsa9 localization to that of peroxisomes, we con-
structed a blue fluorescent protein (BFP) tagged with the
serine-lysine-leucine COOH-terminal peroxisomal target-
ing signal (BFP-SKL; Fig. 7, middle). In glucose adapta-
tion conditions, the intensity of GFP/HA-Gsa9 appeared
strongest at the vacuolar regions that surrounded the per-
oxisomes during the engulfment process (Fig. 7, bottom).
GFP/HA-Gsa9 also formed punctate structures that ap-
peared continuous with its vacuolar membrane labeling
pattern. The distribution of GFP/HA-Gsa9 before and af-
ter glucose adaptation suggests that Gsa9 localizes to re-
gions of the vacuolar membrane that contact peroxisomes
during micropexophagy.
Discussion
Autophagy and the Cvt pathway are overlapping pro-
cesses that share most components. However, the Cvt
pathway operates in a biosynthetic capacity during vegeta-
tive conditions, whereas autophagy is primarily a degrada-
tive process that is induced by starvation. Both pathways
involve dynamic membrane rearrangements to deliver cy-
tosolic contents to the vacuole. Morphological studies sug-
gest that the two pathways normally operate exclusively of
one another. The regulatory mechanisms and structural
differences that control the conversion between the Cvt
pathway and autophagy are not well understood. To gain
further insight into the factors that are distinct between
these pathways, we have examined a protein component,
Cvt9, and its P. pastoris homologue, Gsa9, which appear to
be specific to the Cvt pathway and micropexophagy, re-
spectively.
Cvt9 Forms a Protein Complex Comprised of 
Cvt/Apg Phosphoproteins
Cvt9 exists primarily as a peripherally bound membrane
protein (Fig. 3, B and C). Coimmunoprecipitation results
demonstrate that it forms homodimers or even higher or-
der homooligomers (Fig. 3 A), potentially through a coiled
coil assembly mechanism, as indicated by secondary struc-
tural analysis. Consistent with our recent two-hybrid re-
sults (Kamada et al., 2000), we have demonstrated by
coimmunoprecipitation analysis that Cvt9 directly inter-
acts with the serine/threonine kinase Apg1 (Fig. 5), a com-
ponent essential for both Cvt transport and autophagy.
The association with Apg1 places Cvt9 as a member of a
larger putative protein complex comprised of other com-
ponents of the Cvt and autophagy pathways including
Apg1, Apg13, Apg17, and Vac8 (Kamada et al., 2000;
Scott et al., 2000). However, it remains to be determined if
these Cvt/Apg components assemble into one protein
complex or whether they represent separate, discrete in-
teractions. Recent studies have demonstrated stable physi-
cal interactions between Apg1 and Apg13, Apg1 and
Apg17, and Vac8 and Apg13 (Kamada et al., 2000; Scott et
al., 2000). Apg13, together with Apg1, represent the com-
ponents in the putative protein complex that are required
for both Cvt transport and autophagy (Scott et al., 1996,
2000). In contrast, Apg17 is required for autophagy but
not the Cvt pathway (Kamada et al., 2000), whereas Vac8
does not appear to be essential for autophagy but is re-
quired for the Cvt pathway (Scott et al., 2000). Similar to
the vac8 phenotype, the cvt9 mutant also displays the hall-
marks of a functional autophagy pathway, including viabil-
ity under nutrient deprivation, the ability to transport bulk
cytosol to the vacuole, and the accumulation of autophagic
bodies when vesicle breakdown is pharmacologically in-
hibited (Fig. 1).
The differential effects that Cvt9, Apg1, Apg13, Apg17,
and Vac8 exert on the Cvt and autophagy pathways sug-
gest that these components may serve to regulate the con-
version between Cvt transport and autophagy. Apg1,The Journal of Cell Biology, Volume 153, 2001 394
Apg13, Cvt9, and Vac8 are all phosphoproteins, and the
phosphorylation state and affinity of Apg13 to Apg1 are
regulated by nutrient conditions through the Tor kinase
cascade (Matsuura et al., 1997; Kamada et al., 2000; Scott
et al., 2000). Taken together, these findings suggest that
these regulatory proteins may serve as a junction at which
upstream signals based on nutrient availability are trans-
duced to effect the downstream formation of either Cvt
vesicles or autophagosomes.
The Cvt9 Protein Complex Localizes to a Novel 
Perivacuolar Compartment
The subcellular distribution of GFPCvt9 supports an in-
creasingly familiar localization pattern among Cvt and au-
tophagy components (Kim et al., 1999; Noda et al., 2000).
Specifically, an intense concentration of the GFPCvt9 fu-
sion protein appears at a punctate, perivacuolar structure
(Fig. 4 A). This localization pattern corresponds to a sub-
cellular density profile distinct from other known mem-
brane compartments, including ER, Golgi, and the Pep12-
localized endosome (Fig. 4 B and C). Given that Cvt9
associates with Apg1, which in turn interacts with addi-
tional components essential for autophagy, the Cvt pathway,
and pexophagy, the putative Cvt9 protein complex may
identify, at the molecular level, a novel membrane compart-
ment critical for these modes of subcellular trafficking.
Mechanistic Similarities between the Cvt/Autophagy 
Pathways and Micropexophagy
In P. pastoris, the specific degradation of excess peroxi-
somes during glucose adaptation entails the sequestration
of peroxisomes by the vacuole in the process of micropex-
ophagy. The mechanistic details of how a Cvt vesicle or an
autophagosome forms to sequester cargo appear morpho-
logically similar to the vacuole-mediated engulfment of
peroxisomes. In each case, the sequestration of cargo by a
membrane source results in the formation of a double-
membrane structure. In the case of micropexophagy, the
enwrapping membrane is the vacuole itself whereas the
membrane source in the formation of Cvt vesicles and au-
tophagosomes remains to be determined.
We have identified Gsa9 as the P. pastoris homologue of
Cvt9. The functional analysis of Gsa9 corroborates and may
provide new insights into the role of Cvt9 in S. cerevisiae.
Neither Gsa9 nor Cvt9 is required for autophagy, whereas
both are essential for peroxisome degradation (Figs. 1 and
6). The degradation of peroxisomes in S. cerevisiae may oc-
cur by micropexophagy (Chiang et al., 1996). In P. pastoris,
the uptake of peroxisomes by micropexophagy is easily de-
tected and thus the morphological consequence of a gsa9
mutation can be readily assessed. Electron micrographs re-
veal that the arrest in micropexophagy occurs at a middle
sequestration stage in the gsa9 mutant. That is, the vacu-
ole(s) only partially surrounds the peroxisomes but cannot
complete the engulfment process (Fig. 6 D).
The prAPI phenotype in cvt9 supports a similar defect in
the Cvt pathway. To characterize the direct effect of Cvt9
inactivation, we constructed a Cvt9 temperature-degron
fusion protein (Cvt9td), a novel temperature-conditional
form of Cvt9 (Fig. 2 B). At nonpermissive temperature,
prAPI in the cvt9td strain remained protease accessible
(Fig. 2 C). In addition, prAPI was able to float through a
step gradient in a detergent-dependent manner, suggesting
that it associated with a floatable membrane (Fig. 2 D).
Therefore, the cvt9 defect in the Cvt pathway may be at a
middle-to-late stage in Cvt vesicle formation, analogous to
the gsa9 mutant phenotype for micropexophagy.
Localization of Gsa9 Versus Cvt9
A key difference between Gsa9 and Cvt9 is their subcellu-
lar localization patterns. Before the induction of mi-
cropexophagy, Gsa9 appears to be localized to both a
punctate structure in the perivacuolar region and diffusely
distributed on the vacuole (data not shown). However,
upon glucose adaptation, a population of Gsa9 strongly lo-
calizes to regions of the vacuolar membrane that are in
contact with peroxisomes in the process of being seques-
tered into the vacuole (Fig. 7). In contrast, the localization
of Cvt9 to the perivacuolar compartment appears constant
regardless of nutrient status. If Cvt9 functions analogously
to Gsa9 in the Cvt pathway of S. cerevisiae, then it may di-
rectly participate in the enwrapping of prAPI-containing
Cvt complexes to form the double-membrane Cvt vesicles.
Furthermore, if Cvt9 acts at the site of cargo sequestration
in an analogous manner to the function of Gsa9 at the vac-
uole during peroxisome engulfment, then the Cvt9 local-
ization pattern would identify the perivacuolar compart-
ment as the donor membrane source for Cvt vesicles.
Additional studies will be required to test this assertion.
Potential Function of Gsa9 and Cvt9
Given that the mechanisms of the Cvt pathway and pex-
ophagy are quite similar to autophagy (for review see Kim
and Klionsky, 2000), why is autophagy not affected in the
cvt9 and gsa9 mutants? The function of Cvt9 and Gsa9
may be required for the recognition of specific cargo, such
as prAPI and peroxisomes, but not for the sequestration of
nonspecific bulk cytosol by autophagy. The observation
that Gsa9 appears to be concentrated in a region of the
vacuolar membrane that contacts the peroxisome during
the engulfment process suggests that Gsa9 may function in
the recognition of peroxisomes. Without Gsa9, the proper
associations between the peroxisomal and vacuolar mem-
branes may not exist, resulting in a checkpoint stop in the
engulfment process. The role of Gsa9 and Cvt9 as poten-
tial factors that provide cargo specificity is supported by
the observation that deleting Cvt9 destabilizes the binding
of prAPI-containing Cvt complexes to the membrane (Fig.
2 A). In addition, the role of Cvt9 in prAPI specificity can
also be examined in terms of the prAPI reversal pheno-
type. Under nitrogen starvation conditions, prAPI accu-
mulation is only partially reversed in the cvt9D strain (Fig.
1 C). If a deletion in CVT9 did not affect the selective na-
ture of prAPI import, then one would predict that the en-
tire population of prAPI would enter the vacuole via au-
tophagy. The near complete reversal of prAPI under
starvation conditions is observed in some API propeptide
mutants that retain the ability to bind to the membrane
(Scott et al., 1997). In contrast, the import of the bulk cyto-
solic marker Pho8D60 via autophagy plateaus at z30%.
Therefore, the loss of cargo selectivity in the cvt9D strain
may result in the recognition of prAPI as another nonspe-Kim et al. Cvt9/Gsa9 Functions in the Cvt and Pexophagy Pathways 395
cific molecule during autophagy. Further analysis of Cvt9
and the proteins that associate with it will provide addi-
tional information about the conversion between the Cvt
pathway and autophagy as well as the mechanism that
modulates specificity in the Cvt pathway and pexophagy.
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